CVRdatabase
Menu

Evosep ApS

Private limited companyCVR 37510068Odense MActive

Evosep ApS is a private limited company, based in Odense M, active in research and experimental development on natural sciences and engineering, founded in 2016. The company made a loss in both 2024 and 2025, most recently DKK 221.6m. With 73 employees, the company is about 15 times larger than the industry median. Equity fell to DKK 154.5m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 72.4m+67.8% vs. 2024
Net profit−DKK 221.6m−8,382.1% vs. 2024
EquityDKK 154.5m−38.2% vs. 2024
Employees73latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 68% (2024 → 2025), to DKK 72.4m.
  • The loss grew: from DKK 2.6m to DKK 221.6m (2024 → 2025).
  • Equity fell 38% (2024 → 2025), to DKK 154.5m.

Employees

  • 9 more employees than a year earlier: 73 (07/2026) against 64 (07/2025).

Management and owners, last 24 months

  • New in management: Jens Bornhøft Christensen (board member, 27/11/2025), Morten Bern (board member, 01/05/2026) and Stefan Karl Dieter Wolf (chair of the board, 01/05/2026) (+2).
  • Stepped down: Tonni Bülow-Nielsen (board member, 27/11/2025), Ole Vorm (chair of the board, 27/11/2025) and Stephen Neil van Helden (board member, 28/10/2024) (+2).
  • New owners registered: Paradigm BidCo ApS (27/11/2025).
  • No longer registered as owner: Voma Holding A/S (27/11/2025), Novo Holdings A/S (27/11/2025) and Danmarks Eksport- og Investeringsfond (27/11/2025).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 300m−DKK 200m−DKK 100mDKK 0DKK 100mDKK 200mDKK 300m202020212022202320242025
EquityNet profit
Financial figures for Evosep ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit21,64436,90853,51060,17843,12472,369+67.8%
Operating profit (EBIT)–20,872−110,26420,941−8,602−238,846−2,676.6%
Profit before tax7,85221,139−109,36124,008−3,486−241,088−6,815.9%
Net profit6,16916,675−79,61919,777−2,613−221,637−8,382.1%
Total assets36,95756,768112,240275,306265,917173,069−34.9%
Equity28,53845,214−34,406252,714249,889154,548−38.2%
Liabilities–11,313146,64522,59216,02818,521+15.6%
Cash and cash equivalents15,69920,87827,077162,495161,09748,690−69.8%
Average number of employees131530425560+9.1%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50mDKK 60mDKK 70m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 2 years in a row

    Net result has been negative in 2024–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

  • Equity fell sharply

    Equity fell 38% from 2024 to 2025 (DKK 249.9m to DKK 154.5m).

    How is this calculated?

    Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Evosep ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202521/04/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202424/03/2025The companyPDFXBRL
202301/01/2023 – 31/12/202313/03/2024The groupPDFXBRL
202201/01/2022 – 31/12/202208/04/2023The companyPDFXBRL
202101/01/2021 – 31/12/202128/02/2022The companyPDFXBRL
202001/01/2020 – 31/12/202011/03/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
01020304050607008/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 72.4mNo. 24 of 421
Better than 95% of the companies in the industry
EquityDKK 154.5mNo. 27 of 431
Better than 94% of the companies in the industry
Number of employees73No. 31 of 431
Better than 93% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 50–199 employees4,467 companies in the comparison
No. 1,113of 4,412
Better than 75%
No. 442of 4,466
Better than 90%
Same industry and 50–199 employees27 companies in the comparison
No. 11of 26
Better than 60%
No. 9of 27
Better than 69%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 455of 33,588
Better than 99%
No. 494of 33,687
Better than 99%
All companies of type ApS66,508 companies in the comparison
No. 438of 66,379
Better than 99%
No. 754of 66,505
Better than 99%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Evosep ApSDKK 72.4m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Evosep ApS−DKK 221.6m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Evosep ApSDKK 154.5m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Evosep ApS73
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
Evosep ApS

Management

4 active registrations

Executive management

Executive management at Evosep ApS
NameRoleAppointed
Morten BernCEO02/10/2023

Board of directors

Board of directors at Evosep ApS
NameRoleAppointed
Jens Bornhøft ChristensenBoard member27/11/2025
Morten BernBoard member01/05/2026
Stefan Karl Dieter WolfChair of the board01/05/2026
Founders
Voma Holding A/S
Former management (9)
Former management at Evosep ApS
NameRoleAppointedResigned
Ole VormDirector01/03/201629/06/2016
Ole VormCEO30/06/201601/01/2020
Ole VormBoard member30/06/201602/01/2023
Tonni Bülow-NielsenBoard member30/06/201627/11/2025
Christian RavnsborgCEO01/01/202002/10/2023
Ole VormChair of the board03/01/202327/11/2025
Stephen Neil van HeldenBoard member03/01/202328/10/2024
Daniel MahonyBoard member28/10/202427/11/2025
Morten BernChair of the board27/11/202530/04/2026

Signing rule: Selskabet tegnes af et bestyrelsesmedlem i forening med en direktør eller af den samlede bestyrelse

Address and production units

1 active production units

Billedskærervej 15
5230 Odense M

Odense Municipality · Postcode 5230

Other companies at the address (1)

Production units
Production unitAddressEmployeesP number
Evosep ApSBilledskærervej 15, 5230 Odense M781021218614

Purpose

Selskabets formål er udvikling og markedsføring af laboratorieudstyr, herunder måleinstrumenter og associarede forbrugsvarer samt aktiviteter i tilknytning hertil.

The purpose is quoted from the register in Danish.

Changes year by year

59 registered events
20264 changesmanagement 3 · accounts 1
  • Morten Bern appointed board member
  • Stefan Karl Dieter Wolf appointed chair of the board
  • Morten Bern stepped down as chair of the board
  • Annual report for 2025 published
202511 changesmanagement 5 · ownership 4 · accounts 1 · industry 1
  • Morten Bern appointed chair of the board
  • Jens Bornhøft Christensen appointed board member
  • Daniel Mahony stepped down as board member
  • Ole Vorm stepped down as chair of the board
  • Tonni Bülow-Nielsen stepped down as board member
  • Paradigm BidCo ApS registered as owner (100%)
  • Danmarks Eksport- og Investeringsfond is no longer registered as owner
  • VOMA HOLDING A/S is no longer registered as owner
  • Novo Holdings A/S is no longer registered as owner
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20244 changesmanagement 2 · address 1 · accounts 1
  • Daniel Mahony appointed board member
  • Stephen Neil van Helden stepped down as board member
  • Moved to Billedskærervej 15, 5230 Odense M
  • Annual report for 2023 published
202314 changesmanagement 5 · accounts 1 · ownership 7 · capital 1
  • Morten Bern appointed ceo
  • Christian Ravnsborg stepped down as ceo
  • Annual report for 2022 published
  • Danmarks Eksport- og Investeringsfond registered as owner (25%)
  • VÆKSTFONDEN is no longer registered as owner
  • Share capital changed from 161,838 DKK to 207,131 DKK
  • Stephen Neil van Helden appointed board member
  • Ole Vorm appointed chair of the board
  • VÆKSTFONDEN registered as owner (25%)
  • VOMA HOLDING A/S registered as owner (33.33%)
  • Novo Holdings A/S registered as owner (20%)
  • Ole Vorm stepped down as board member
  • VÆKSTFONDEN is no longer registered as owner
  • VOMA HOLDING A/S is no longer registered as owner
20221 changeaccounts 1
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20203 changesaddress 1 · management 2
  • Moved to Buchwaldsgade 35, 3, 5000 Odense C
  • Christian Ravnsborg appointed ceo
  • Ole Vorm stepped down as ceo
20182 changescapital 2
  • Share capital changed from 133,727 DKK to 161,838 DKK
  • Share capital changed from 105,555 DKK to 133,727 DKK
20171 changecapital 1
  • Share capital changed from 83,333 DKK to 105,555 DKK
201618 changescapital 2 · ownership 8 · address 1 · name 1 · management 5 · founded 1
  • Share capital changed from 66,667 DKK to 83,333 DKK
  • VÆKSTFONDEN registered as owner (20%)
  • VOMA HOLDING A/S registered as owner (66.67%)
  • VOMA HOLDING A/S is no longer registered as owner
  • VÆKSTFONDEN is no longer registered as owner
  • Moved to Thriges Plads 6, 5000 Odense C
  • Name changed from Omics Ready Biosystems ApS to Evosep ApS
  • Share capital changed from 50,000 DKK to 66,667 DKK
  • Tonni Bülow-Nielsen appointed board member
  • Ole Vorm appointed board member
  • Ole Vorm appointed ceo
  • VOMA HOLDING A/S registered as owner (90%)
  • VÆKSTFONDEN registered as owner (0%)
  • Ole Vorm stepped down as director
  • VOMA HOLDING A/S is no longer registered as owner
  • Registered as Omics Ready Biosystems ApS
  • Ole Vorm appointed director
  • VOMA HOLDING A/S registered as owner (100%)

Related companies

Same industry in Odense

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction